What is the treatment for a patient with a severe allergy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Severe Allergy (Anaphylaxis)

Intramuscular epinephrine is the only first-line treatment for severe allergic reactions (anaphylaxis) and must be administered immediately—there is no substitute. 1, 2

Immediate Management Algorithm

First-Line Treatment: Epinephrine

  • Administer epinephrine 0.01 mg/kg IM (maximum 0.5 mg per dose) into the anterior-lateral thigh immediately upon recognition of anaphylaxis 2
  • For patients >25 kg: use 0.3 mg epinephrine autoinjector 2
  • For patients 10-25 kg: use 0.15 mg epinephrine autoinjector 2
  • May repeat every 5-15 minutes if symptoms persist or progress 2
  • Epinephrine acts rapidly to reverse nearly all symptoms of anaphylaxis and stabilizes mast cells 3

Critical Pitfall: Using antihistamines as primary treatment is the most common reason for not administering epinephrine and significantly increases risk of progression to life-threatening reactions 1, 2. Never delay epinephrine to give antihistamines. 2

Positioning and Supportive Care

  • Place patient recumbent with lower extremities elevated if tolerated 2
  • Administer supplemental oxygen 2
  • Establish IV access for fluid resuscitation 1

Respiratory Support

  • For persistent wheezing: albuterol nebulizer 1.5 mL (child) or 3 mL (adult) every 20 minutes or continuously as needed 2
  • For patients with albuterol allergy: use ipratropium bromide as alternative bronchodilator 4

Second-Line Adjunctive Therapy

These medications should ONLY be given AFTER epinephrine, never as substitutes: 2, 5

H1 Antihistamines

  • Diphenhydramine 1-2 mg/kg IV or oral (maximum 50 mg) 2
  • Oral liquid formulation absorbs faster than tablets 2
  • Relieves itching and urticaria but does NOT treat bronchospasm or hypotension 2, 5

H2 Antihistamines

  • Ranitidine 1-2 mg/kg (maximum 75-150 mg) IV or oral 2
  • Combination of H1 and H2 antihistamines works better than either alone 2

Corticosteroids

  • Methylprednisolone 1 mg/kg IV (maximum 60-80 mg) OR prednisone 1 mg/kg oral (maximum 60-80 mg) 2, 6
  • Used to prevent biphasic or protracted reactions, though evidence is limited 1
  • Effects not apparent for 4-6 hours, but early administration hastens resolution 4

Management of Refractory Anaphylaxis

  • Repeated doses of epinephrine, IV fluids, corticosteroids, and vasopressor agents may be needed 1
  • Prompt transfer to intensive care unit for treatment and monitoring is essential 1
  • For patients on beta-blockers with reduced epinephrine response: glucagon 20-30 μg/kg (children) or 1-5 mg (adults) 2

Observation Period

  • Observe for 4-6 hours or longer based on severity of reaction 1
  • Monitor for biphasic reactions, which can occur hours after initial resolution 1

Discharge Planning and Long-Term Management

Prescriptions at Discharge

  • Prescribe TWO epinephrine autoinjectors with proper training on use 1, 2
  • Continue diphenhydramine every 6 hours for 2-3 days 1, 2
  • Continue H2 antihistamine (ranitidine) twice daily for 2-3 days 1, 2
  • Continue prednisone daily for 2-3 days 1, 2, 6

Patient Education

  • Provide written anaphylaxis emergency action plan 1, 7
  • Train on early recognition of anaphylaxis signs and symptoms 1
  • Educate on allergen avoidance strategies 1
  • Recommend medical identification jewelry or anaphylaxis wallet card 1

Follow-Up

  • Schedule follow-up with primary care provider and refer to allergist/immunologist 1, 2
  • Allergist evaluation for trigger identification and consideration of immunotherapy if indicated 2, 5

Special Populations Requiring Heightened Vigilance

  • Patients with asthma are at particularly high risk for fatal anaphylaxis 2
  • Presence of wheezing in asthmatic patients having allergic reaction mandates immediate epinephrine 2
  • Patients with cardiovascular disease, those on MAO inhibitors, tricyclic antidepressants, or stimulant medications require careful risk-benefit assessment, but epinephrine benefit usually outweighs risks 1
  • There are no absolute contraindications to epinephrine use in anaphylaxis 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Second-Line Treatment for Allergic Reactions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Epinephrine in the Management of Anaphylaxis.

The journal of allergy and clinical immunology. In practice, 2020

Guideline

Emergency Bronchodilator Alternatives for Albuterol Allergy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Allergy Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.